O

    Oncology Institute Inc (TOI)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $5.13
    +0.27 (+5.56%)

    Market Cap: $512.91M

    Last updated: Aug 03, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    27%(4/15)
    Avg Surprise
    -49.67%
    Streak
    2 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.04
    Range$-0.06 - $0.00
    5 analysts
    EPS RevisionsNo revisions (7d)
    2
    1
    30d
    EPS Estimate Drift
    90d ago$-0.05-45.8%
    60d ago$-0.04-4.2%
    30d ago$-0.04-25.0%
    7d ago$-0.04-25.0%
    Current$-0.04
    Revenue Consensus
    $171M
    Range$166M - $178M
    5 analysts
    Dec 31, 2026
    EPS Consensus$0.05
    Range$0.01 - $0.10
    5 analysts
    Revenue Consensus
    $187M
    Range$172M - $208M
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.05---
    Sep 26EST
    		-$-0.04---
    Jun 26
    		$N/A$-0.07N/ABeat-
    Mar 26
    		$-0.02N/A+77.78%Beat+90.4%
    Dec 25
    		$-0.06$-0.09+29.67%Beat+55.7%
    Sep 25
    		$-0.14$-0.11-27.27%Miss+20.0%
    Jun 25
    		$-0.15$-0.12-25.00%Miss-7.1%
    Mar 25
    		$-0.21$0.00N/ABeat-9.7%
    Dec 24
    		$-0.14$-0.08-78.75%Miss+31.9%
    Sep 24
    		$-0.18$-0.06-191.83%Miss-391.8%
    Jun 24
    		$-0.14$-0.10-40.00%Miss+26.3%
    Mar 24
    		$-0.19$-0.12-58.33%Miss+42.4%
    Dec 23
    		$-0.21$-0.11-90.91%Miss+4.5%
    Sep 23
    		$0.06N/A+146.15%Beat+106.8%
    Jun 23
    		$-0.19$-0.17-11.76%Miss-111.1%
    Mar 23
    		$-0.33$-0.17-94.12%Miss-232.0%
    Dec 22
    		$-0.22$-0.20-10.00%Miss-57.1%
    Sep 22
    		$-0.88$-0.18-388.89%Miss-4300.0%
    Jun 22
    		$-0.09$-0.11+18.18%Beat+57.1%
    Mar 22
    		$0.25N/AN/ABeat+25.0%
    Dec 21
    		$-0.14N/AN/ABeat-1300.0%
    Sep 21
    		$-0.02N/AN/ABeat-316.7%
    Jun 21
    		$-0.21N/AN/ABeat-5150.0%
    Mar 21
    		$0.20N/AN/ABeat-
    Dec 20
    		$-0.01N/AN/ABeat-
    Sep 20
    		$-0.00N/AN/ABeat-
    Jun 20
    		$-0.00N/AN/ABeat-
    Mar 20
    		$0.00$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDA8.53x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin-7.97%Operating Margin-4.42%
    ROE-652.00%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    Beta0.42Avg VolumeN/A
    52-Week High$6.6752-Week Low$2.32

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$5.07
    SMA 20$5.41
    SMA 50$5.16
    SMA 200$3.86
    EMA 10$5.10
    EMA 20$5.21
    EMA 50$5.02
    EMA 200$4.00

    MACD

    Line: -0.08Signal: 0.00Hist: -0.08

    ADX

    ADX: 18.0+DI: 19.4-DI: 20.3

    Aroon & PSAR

    Aroon Up44.0
    Aroon Down84.0
    PSAR$5.44

    Bollinger Bands

    Upper Band$6.29
    Lower Band$4.53
    %B Position3251%(Upper)
    Band Width0.34

    RSI (14-Day)

    Neutral
    48.5

    Momentum Oscillators

    Stoch %K17.9
    Stoch %D13.2
    Williams %R-73.3
    ROC (10d)-6.7%
    Momentum-0.37
    CCI (20d)-72.1
    MFI (14d)22.5

    Volatility Measures

    ATR (14d)$0.38(7.3%)
    StdDev (20d)0.44
    Hist Vol75.3%(High)

    Volume Flow

    VWAP$5.05
    OBV58.9M
    AD Line-5.0M
    CMF (20d)-0.013

    Volume Metrics

    Avg Vol (20d)1.9M
    Vol Ratio0.7x
    VWMA (20d)$5.55

    Pivot Points

    R3$5.51
    R2$5.38
    R1$5.12
    Pivot Point$4.99
    S1$4.73
    S2$4.60
    S3$4.34

    Advanced Oscillators

    TSI-5.44
    Ultimate Osc42.8
    KST-15.28

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$161.28M$147.44M$141.96M$136.56M$119.80M$104.41M$100.27M$99.90M$98.58M$94.67M$85.79M$82.03M
    Cost of RevenueN/A$125.74M$119.19M$117.64M$102.30M$87.16M$85.63M$85.53M$85.55M$82.70M$71.41M$66.06M
    Gross ProfitN/A$21.70M$22.77M$18.92M$17.50M$17.25M$14.64M$14.37M$13.03M$11.97M$14.38M$15.98M
    Operating Expenses$165.89M$153.79M$148.91M$144.77M$131.07M$114.36M$112.15M$113.73M$114.39M$112.64M$99.83M$96.14M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$0$0$0$0$0$0$0$0$0$0$0$0
    Operating IncomeN/A$-6,513,000$-6,907,000$-8,054,000$-11,211,000$-9,911,000$-11,929,000$-13,853,000$-16,364,000$-17,972,000$-15,288,000$-13,925,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$1.92M$0$0$0$1.17M$0$0$0$1.94M$0
    Income Before Tax$-9,789,000$-2,492,000$-7,508,000$-16,504,000$-17,140,000$-19,585,000$-13,182,000$-16,113,000$-15,479,000$-19,889,000$-19,068,000$-17,284,000
    Income Tax Expense$0$0$0$0$-131,000$0$0$0$0$0$-314,000$135,000
    Net Income$-9,789,000$-2,492,000$-7,508,000$-16,504,000$-17,009,000$-19,585,000$-13,182,000$-16,113,000$-15,479,000$-19,889,000$-18,754,000$-17,419,000
    EBITDA$-1,516,000$-3,518,000$-4,114,000$-5,309,000$-8,330,000$-3,296,000$-8,582,000$-10,721,000$-12,856,000$-15,248,000$-12,813,000$-9,964,000
    EBIT$-4,610,000$-6,345,000$-6,951,000$-8,204,000$-11,264,000$-9,954,000$-11,882,000$-13,833,000$-15,812,000$-17,972,000$-14,043,000$-14,105,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about TOI

    News

    The Oncology Institute, Inc. (STLN) Income Statement

    The article provides the income statement for The Oncology Institute, Inc. (STLN) showing financial data for annual and quarterly periods up to 2025-12-31, with a TTM (trailing twelve months) column. Key financial metrics such as total revenue, gross profit, operating income, and net income are detailed, indicating the company's financial performance.

    Yahoo! Finance Canada•8/7/26•
    Neutral

    The Oncology Institute, Inc. $TOI Shares Bought by Arrowstreet Capital Limited Partnership

    Arrowstreet Capital Limited Partnership significantly increased its stake in The Oncology Institute, Inc. ($TOI) by 169.3% in the first quarter, now owning 419,423 shares valued at approximately $1.29 million. Other institutional investors like Goldman Sachs and Geode Capital Management also made notable changes to their holdings. The company has a "Moderate Buy" consensus rating from analysts, with an average price target of $8.50, and recently reported mixed earnings with revenue exceeding expectations but a slightly wider loss per share.

    MarketBeat•8/7/26•
    Somewhat-Bullish

    Oncology Institute Q2 Earnings Call Highlights

    Oncology Institute reported strong Q2 revenue growth, positive adjusted EBITDA, and rebranded as Starling Oncology to reflect its evolution into a national value-based oncology provider. The company expanded its value-based contracts, adding new agreements in Nevada, Oregon, and California, which are expected to significantly boost capitated lives and revenue. Starling Oncology also launched a new provider portal, completed a refinancing, and raised its full-year revenue and gross-profit outlook.

    TradingView•8/7/26•
    Bullish

    Form 8K Oncology Institute Inc For: 6 August By Investing.com

    The article reports on an 8K filing by Oncology Institute Inc. for August 6. It includes a stock market publication timestamp and references the company's stock symbol STLN. The content also features various market data, trending stocks, and related news headlines.

    Investing.com Canada•8/6/26•
    Neutral

    The Oncology Institute, Inc. Revenue Breakdown – NASDAQ:STLN

    The Oncology Institute, Inc. (NASDAQ: STLN) generated $502.73 million in revenue last year, with its Dispensary segment being the top performer, contributing $269.18 million. The majority of its revenue, $502.73 million, originated from the United States. This indicates a strong domestic market for the company's services, particularly within its dispensary operations.

    TradingView•8/5/26•
    Neutral

    Frequently Asked Questions About TOI

    Does TOI pay dividends?
    Oncology Institute Inc (TOI) does not currently pay a regular dividend.
    What is TOI's market cap?
    Oncology Institute Inc (TOI) has a market capitalization of $512.91M with a current stock price of $5.13.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In